Ari Landon

Ari Landon, PhD, MBA, currently serves as the VP of Life Sciences at Elevate Ventures, focusing on mentoring and financially enabling life science companies across various sectors. Previously, Ari held the position of Vice President of Business Development at Cornerstone Pharmaceuticals, where partnership opportunities were identified, licensing terms negotiated, and scientific strategy developed for assets. Ari has also contributed as a Subject Matter Expert at Kingswood U.S. and as Head of Search and Evaluation at Rafael Holdings, Inc., overseeing scientific diligence and operational responsibilities in business development. Additional roles include Division President at Rafael Medical Devices, Strategic Advisor at Nagarro, and Executive Director/COO at the Barer Institute, where a pharmaceutical pipeline for aggressive cancer treatment was developed. Educational qualifications include an MBA from NYU Stern School of Business, a Postdoc in Biochemistry and Pharmacology from Yale University, a PhD in Biochemistry and Molecular Biology from the University of Maryland School of Medicine, and a Bachelor’s degree in Biology from Yeshiva University.